Diagnosis and treatment of pathologic gambling

Current Psychiatry Reports

Volumn 5, Issue 1, 2003, Pages 9-15

  Sood, Erica D ^b   Pallanti, Stefano ^b   Hollander, Eric ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CITALOPRAM; CLOMIPRAMINE; DOPAMINE; FLUVOXAMINE; LITHIUM; LITHIUM CARBONATE; NALTREXONE; NEFAZODONE; NORADRENALIN; OPIATE ANTAGONIST; PAROXETINE; PLACEBO; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VALPROIC ACID;

ATTENTION DEFICIT DISORDER; CLINICAL TRIAL; COMORBIDITY; DAILY LIFE ACTIVITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOPAMINERGIC SYSTEM; DRUG EFFICACY; FAMILY LIFE; HUMAN; HUMAN RELATION; HYPOMANIA; IMPULSE CONTROL DISORDER; JOB PERFORMANCE; MALADJUSTMENT; MANIA; MEDICAL RESEARCH; MOOD DISORDER; NEUROBIOLOGY; NORADRENERGIC SYSTEM; PATHOLOGICAL GAMBLING; POPULATION RESEARCH; REVIEW; SEROTONINERGIC SYSTEM; SUBSTANCE ABUSE; TREATMENT OUTCOME; UNITED STATES; ADULT; PSYCHOLOGICAL ASPECT;

ADULT; GAMBLING; HUMANS; IMPULSE CONTROL DISORDERS;

EID: 0642314885     PISSN: 15233812     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11920-003-0003-7     Document Type: Review

References (86)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, edn 4. Washington, DC: American Psychiatric Association; 1994.
2. Blakeslee S: Suicide rate higher in three gambling cities, study says. New York Times. December 16, 1997.
3. Ciarrocchi J, Richardson R: Profile of compulsive gamblers in treatment: update and comparisons. J Gambling Behav 1989, 5:53-65.
4. Lesieur HR, Blume SB: Characteristics of pathological gamblers among patients on a psychiatric admissions service. Hosp Community Psychiatry 1990, 41:1-12.
5. Livingston J: Compulsive Gamblers: Observations on Action and Abstinence. New York: Harper Torchbooks; 1974.
6. National Council on Problem Gambling: National Council on Problem Gambling Research and Public Policy Committees: Problem and Pathological Gambling in America: The National Picture. Coulmbia, MD: National Council on Problem Gambling; 1997.
7. Volberg RA: The prevalence and demographics of pathological gamblers: implications for public health. Am J Pub Health 1994, 84:237-241.
8. Commision on the Review of the National Policy Toward Gambling: In Gambling in America. Washington, DC: US Government Printing Office; 1976.
9. Lesieur HR, Cross J, Frank M, et al.: Gambling and pathological gambling among college students. Addict Behav 1991, 16:517-527.
10. Lesieur HR, Klein R: Gambling and pathological gambling among high school students. Addict Behav 1987, 12:129-135.
11. Shaffer HJ: Estimating the prevalence of adolescent gambling: a quantitative synthesis and guide toward standard gambling nomenclature. J Gambling Stud 1996, 12:193-214.
12. Lesieur HR: The female pathological gambler. In Gambling Studies and Proceedings of the Seventh International Conference on Gambling and Risk Taking. Edited by Eadington WR. Reno: University of Nevada; 1988.
13. Lester D: Access to gambling opportunities and compulsive gambling. Int J Addict 1994, 29:1611-1616.
14. McCormick RA, Russo AM, Ramirez LF, et al.: Affective disorders among pathological gamblers seeking treatment. Am J Psychiatry 1984, 141:215-218.
15. Linden RD, Pope HG, Jonas JM: Pathological gambling and major affective disorders: preliminary findings. J Clin Psychiatry 1986, 47:201-203.
16. Specker SM, Carlton GA, Christenson GA, et al.: Impulse control disorders and attention deficit disorder in pathological gamblers. Ann Clin Psychiatry 1995, 7:175-179.
17. Carlton PL, Goldstein L: Physiological determinants of pathological gambling. In A Handbook of Pathological Gambling. Edited by Glaski T. Springfield: Charles C. Thomas; 1987:657-663.
18. Stegman M, Regard M, Landis T, et al.: Pathological gambling: neuropsychological and EEG findings. Presented at the 19th Annual Meeting of the International Neuropsychology Society; San Antonio, TX, February 13-19, 1991.
19. Roy A, Custer R, Lorenz V, et al.: Depressed pathological gamblers. Acta Psychiatr Scand 1988, 77:163-165.
20. Roy A, Adinoff B, Roehrich L, et al.: Pathological gambling: a psychobiological study. Arch Gen Psychiatry 1988, 45:369-373.
21. DeCaria C, Hollander E, Nora R, et al.:Gambling: biological/genetic, treatment, government, and gambling concerns: neurobiology of pathological gambling. Presented at the American Psychiatric Association Annual Meeting; San Diego, CA, May 20, 1997.
22. Bergh C, Eklund T, Sodersten P, et al.: Altered dopamine function in pathological gambling. Psychol Med 1997, 27:473-475.
23. Blum K, Braverman ER, Wu S, et al.: Association of polymorphisms of dopamine D2 receptor (DRD2), and dopamine transporter (DAT1) genes with schizoid/avoidant behaviors (SAB). Mol Psychiatry 1997, 2:239-246.
24. Comings DE: The molecular genetics of pathological gambling. CNS Spectrums 1998, 3:20-37.
25. Perez de Castro I, Ibanez A, Torrez P, et al.: Genetic association study between pathological gambling and a functional DNA polymorphism at the D4 receptor gene. Pharmacogenetics 1997, 7:345-348.
26. Tye NC, Iverson SD, Green AR: The effects of benzodiazepines and serotonin manipulations on punished responding. Neuropharmacology 1979, 18:689-695.
27. Levitt P, Pintar JE, Braekefield XO: Immunocytochemical demonstration of monamine oxidase B in brain astrocytes and serotonin neurons. Proc Natl Acad Sci U S A 1982, 70:6385-6389.
28. Perris C, Jacobson L, von Knorring L, et al.: Enzymes related to biogenic amine metabolism and personality characteristics in depressed patients. Acta Psychiatr Scand 1980, 61:477-484.
29. Schalling D, Asberg M: Biological and psychological correlates of impulsiveness and monotony avoidance. In The Biological Foundations of Personality and Behavior. Edited by Strelau J, Farley FH, Gale A. New York: Hemisphere Press; 1985:181-194.
30. Murphy KL, Belmaker R, Buchsbaum MS: Biogenic amine related enzymes and personality variations in normals. Psychol Med 1977, 7:149-157.
31. von Knorring L, Oreland L, Winblad B: Personality traits related to monoamine oxidase activity in platelets. Psychiatry Res 1984, 12:11-26.
32. Ward PB, Catts SV, Norman TR, et al.: Low platelet monoamine oxidase and sensation seeking in males: an established relationship? Acta Psychiatr Scand 1987, 75:86-90.
33. Buchsbaum MS, Haier RJ, Murphy DL: Suicide attempts, platelet monoamine oxidase, and the average evoked response. Acta Psychiatr Scand 1977, 56:69-79.
34. Gottfries CG, von Knorring L, Oreland L: Platelet monoamine oxidase activity in mental disorder. II: affective psychoses and suicidal behavior. Prog Neuro Psychopharmacol 1980, 4:185-192.
35. Blanco C, Orensanz-Mundz L, Blanco-Jerez C, et al.: Pathological gambling and platelet MAO activity: a psychobiological study. Am J Psychiatry 1996, 153:119-121.
36. Carrasco J, Saiz-Ruiz J, Moreno I, et al.: Low platelet monoamine oxidase activity in pathological gambling. Acta Psychiatr Scand 1994, 90:427-431.
37. Virkkunen M, Nuutila A, Goodwin F, et al.: Cerebrospinal fluid monoamine metabolite levels in male arsonists. Arch Gen Psychiatry 1987, 44:241-247.
38. Moreno I, Saiz-Ruiz J, Lopez-Ibor JJ: Serotonin and gambling dependence. Human Psychopharmacol 1991, 6(suppl):S9-S12.
39. DeCaria CM, Hollander E, Grossman R, et al.: Diagnosis, neurobiology and treatment of pathological gambling. J Clin Psychiatry 1996, 57:80-84.
40. Decaria CM, Begaz T, Hollander E: Serotonergic and noradrenergic function in pathological gambling. CNS Spectrums 1998, 3:38-47.
41. Rasmussen SA: Obsessive compulsive spectrum disorders. J Clin Psychiatry 1994, 55:89-91.
42. Perse TL, Greist JH, Jefferson JW, et al.: Fluvoxamine treatment of obsessive-compulsive disorder. Am J Psychiatry 1988, 144:1543-1548.
43. Goodman WK, Price LH, Rasmussen SA, et al.: The efficacy of fluvoxamine in obsessive compulsive disorder: a double-blind comparison with placebo. Arch Gen Psychiatry 1989, 46:36-44.
44. Koran LM, McElroy SL, Davidson JR, et al.: Fluvoxamine versus clomipramine for obsessive-compulsive disorder: a double-blind comparison. J Clin Psychopharmacol 1996, 16:121-129.
45. Mundo E, Maina G, Uslenghi C: Multicenter, double-blind, comparison of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder. Int Clin Psychopharmacol 2000, 15:69-76.
46. Phillips KA, Dwight MM, McElroy SL: Efficacy and safety of fluvoxamine in body dysmorphic disorder. J Clin Psychiatry 1998, 59:165-71.
47. Hollander E, Cohen LJ, Simeon D, et al.: Fluvoxamine treatment of body dysmorphic disorder. J Clin Psychopharmacol 1994, 14:75-77.
48. Hollander E, Allen A, Kwon J: Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness. Arch Gen Psychiatry 1999, 56:1033-1039.
49. Swedo SE, Leonard HL, Rapoport JL, et al.: A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania. N Engl J Med 1989, 321:497-501.
50. Casals-Ariet C, Cullen K: Exhibitionism treated with clomipramine. Am J Psychiatry 1993, 150:1273-1274.
51. Zohar J, Zeev K, Benjamin J: Compulsive exhibitionism successfully treated with fluvoxamine: a controlled case study. J Clin Psychiatry 1994, 55:86-88.
52. Lepkifker E, Dannon PN, Ziv R, et al.: The treatment of kleptomania with serotonin reuptake inhibitors. Clin Neuropharmacol 1999, 22:40-43.
53. Hollander E: Obsessive-compulsive spectrum disorders: an overview. Psychiatr Ann 1993, 23:355-358.
54. Hollander E, Kwon JH, Stein DJ, et al.: Obsessive-compulsive and spectrum disorders: overview and quality of life issues. J Clin Psychiatry 1996, 57(suppl 8):3-6.
55. Hollander E: Treatment of obsessive-compulsive spectrum disorders with SSRIs. Brit J Psychiatry 1998, 173(suppl 35): 7-12.
56. Hollander E, Frenkel M, DeCaria C, et al.: Treatment of pathological gambling with clomipramine. Am J Psychiatry 1992, 149:710-711.
57. Hollander E, DeCaria CM, Mari E, et al.: Short-term single-blind fluvoxamine treatment of pathological gambling. Am J Psychiatry 1998, 155:1781-1783.
58. Hollander E, DeCaria CM, Finkell JN, et al.: A randomized double-blind fluvoxamine/placebo crossover trial in pathologic gambling. Biol Psychiatry 2000, 47:813-817.
59. Blanco C, Petkova E, Ibanez A, Saiz-Ruiz J: A pilot placebo-controlled study of fluvoxamine for pathological gambling. Ann Clin Psychiatry 2002, 14:9-15.
60. Zohar J, Judge R: Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. Br J Psychiatry 1996, 169:468-474.
61. Kim SW, Grant JE, Adson DE, et al.: A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling. J Clin Psychiatry 2002, 63:501-507.
62. Montgomery SA, Kasper S, Stein DJ, et al.: Citalopram 20 mg, 40 mg and 60 mg are all effective and well tolerated compared with placebo in obsessive-compulsive disorder. Int Clin Psychopharmacol 2001, 16:75-86.
63. Perna G, Bertani A, Caldirola D, et al.: A comparison of citalopram and paroxetine in the treatment of panic disorder: a randomized, single-blind study. Pharmacopsychiatry 2001, 34:85-90.
64. Simon NM, Sharma SG, Worthington JJ, et al.: Citalopram for social phobia: a clinical case series. Prog Neuropsychopharmacol Biol Psychiatry 2001, 25:1469-74.
65. Zimmerman M, Breen RB, Posternak MA: An open-label study of citalopram in the treatment of pathological gambling. J Clin Psychiatry 2002, 63:44-48.
66. Coleman E, Gratzer T, Nesvacil L, Raymond NC: Nefazodone and the treatment of nonparaphilic compulsive sexual behavior: a retrospective study. J Clin Psychiatry 2000, 61:282-284.
67. Pallanti S, Baldini-Rossi N, Sood E, Hollander E: Nefazadone treatment of pathological gambling: a prospective open label controlled trial. J Clin Psychiatry 2003, In press.
68. Herridge P, Gold MS: Pharmacological adjuncts in the treatment of opioid and cocaine addicts. J Psychoactive Drugs 1988, 20:233-242.
69. Keuler DJ, Altemus M, Michelson D, et al.: Behavioral effects of naloxone infusion in obsessive compulsive disorder. Biol Psychiatry 1996, 40:154-156.
70. Marrazzi MA, Bacon JP, Kinzie J, Luby ED: Naltrexone use in the treatment of anorexia nervosa and bulimia nervosa. Int Clin Psychopharmacol 1995, 10:163-172.
71. Roth AS, Ostroff RB, Haffman RE: Naltrexone as a treatment for repetitive self-injurious behavior: an open-label trial. J Clin Psychiatry 1996, 57:233-237.
72. Crockford DN, El-Guebaly N: Naltrexone in the treatment of pathological gambling and alcohol dependence. Can J Psychiatry 1998, 43:86.
73. Kim SW, Grant JE: An open naltrexone treatment study in pathological gambling disorder. Int Clin Psychopharmacol 2001, 16:285-289.
74. Kim SW, Grant JE, Adson DE, Shin YC: Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol Psychiatry 2001, 49:914-921.
75. Howland RH: Induction of mania with serotonin reuptake inhibitors. J Clin Psychopharmacol 1996, 16:425-427.
76. Go FS, Malley EE, Birmaher B, et al.: Manic behaviors associated with fluoxetine in three 12- to 18-year-olds with obsessive-compulsive disorder. J Child Adolesc Psychopharmacol 1998, 8:73-80.
77. Diler RS, Avci A: SSRI-induced mania in obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 1999, 38:6-7.
78. Heimann SW, March JS: SSRI-induced mania. J Am Acad Child Adolesc Psychiatry 1996, 35:4.
79. Hollander E, Allen A, Prieto Lopez R, et al.: A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder. J Clin Psychiatry 2001, 62:199-203.
80. Stein DJ, Simeon D, Frenkel M, et al.: An open trial of valproate in borderline personality disorder. J Clin Psychiatry 1995, 56:506-510.
81. Christenson GA, Popkin MK, Mackenzie TB, Realmuto GM: Lithium treatment of chronic hair pulling. J Clin Psychiatry 1991, 52:116-120.
82. Haller R, Hinterhuber H: Treatment of pathological gambling with carbamazepine. Pharmacopsychiatry 1994, 27:129.
83. Moskowitz JA: Lithium and lady luck: use of lithium carbonate in compulsive gambling. NY State J Medicine 1980, 80:785-788.
84. Pallanti S, Quercioli L, Sood E, Hollander E: Lithium and valproate treatment of pathological gambling: a randomized single-blind study. J Clin Psychiatry 2002, 63:559-564.
85. Hollander E, Pallanti S, Baldini-Rossi N, Sood E: Sustained release lithium/placebo treatment response in bipolar spectrum pathological gamblers. Poster presented at the 42nd Annual New Clinical Drug Evaluation Unit Meeting, Boca Raton, FL., June 11, 2002.
86. Hollander E, Begaz T, DeCaria, CM: Pharmacological approaches in the treatment of pathological gambling. CNS Spectrums 1998, 3:72-80.